Biodegradable stents for the treatment of refractory or recurrent benign Oesophageal Stenosis

Home  /  National Uptake and Case Studies  /  Biodegradable stents for the treatment of refractory or recurrent benign Oesophageal Stenosis
CountryAgencyStatusLinkDetails on adaptation processContact information
AustriaLBI-HTAPublished 2015Link to report
In German
The EUnetHTA assessment was translated into German; tables were directly used from the EUnetHTA assessment. National data on e.g. burden of disease/cost were added whenever available. Claudia Wild
claudia.wild@hta.lbg.ac.at
AustriaHVBUsed in direct decision-making. Gottfried Endel
gottfried.endel@hvb.sozvers.at
SlovakiaMoH SKUsed in cross-checking evidence. Tomas Tesar
tomas.tesar@union.sk
SpainAETSAUsed in direct decision-making. Teresa Molina Lopez
mariat.molina.lopez@juntadeandalucia.es
CroatiaAAZ2015-Summary of information from the report for decision makersMirjana Huic (Mirjana.Huic@aaz.hr)